Global Learning Council / National Science Foundation
Subra Suresh is the President of the Global Learning Council, Director of the Boards of HP Inc. and the Singapore Exchange, and the Vannevar Bush Professor Emeritus at MIT.
Nominated by the President of US, he served as Director of the US National Science Foundation. He has also served as President of Carnegie Mellon University and Nanyang Technological University (Singapore), and as MIT’s Dean of Engineering.
Suresh has been awarded 20 honorary doctorates and the Padma Shri from the President of India. For his pioneering research, he has been elected to all three US National Academies: Sciences,
Engineering, and Medicine.
Stanford School of Medicine & Dept.
Microbiology & Immunology, Stanford University
Jeffrey Glenn, M.D., Ph.D. is a Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology at Stanford University, and Director of ViRx@Stanford, the Stanford Biosecurity and Pandemic Preparedness Initiative.
He also heads a research laboratory focused on studying molecular virology and the translation of that knowledge into novel antiviral strategies, as well as the development of new treatments for liver diseases and cancer.
He is the founder of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), co-founder of Riboscience LLC, founder of I-Cubed Therapeutics, and co-cofounder of 4J Therapeutics, Inc., biotechnology companies developing several new classes of antiviral and anti-cancer drugs.
Deputy Scientific Director
National Human Genome Research Institute,
National Institutes of Health
Dr. Paul Liu, a tenured senior investigator at NHGRI, has made significant contributions to leukemia research. He discovered the CBFB-MYH11 fusion gene, illustrated its importance using animal models, and made significant discoveries about normal leukemia genes. His group has also studied familial platelet disorder with associated myeloid malignancy. Dr. Liu earned his medical degree and Ph.D. in human genetics from the University of Texas and received postdoctoral research training at the
University of Michigan. He joined NHGRI in 1993 and has held several positions, including deputy scientific director. Dr. Liu has received several honors, including the NIH Director's Award.
Shaun Patel is the co-founder and CEO of REACT Neuro. This digital health company uses virtual reality and machine learning
to revolutionize the assessment and treatment of brain health. With his leadership, patients can now receive medical attention from the comfort of their homes. Additionally, Patel is the founding General Partner of DRADS Capital, a venture capital fund based in Boston and British Columbia that invests in innovative healthcare, energy, and technology technologies. Before his entrepreneurial journey, he was a Massachusetts General Hospital and Harvard Medical School faculty member. He significantly contributed to neural code research in awake-and-behaving human subjects undergoing deep brain stimulation surgery. With graduate degrees in medical sciences, neuroscience, and machine learning from the Boston University School of Medicine and Harvard Medical School, Patel brings vast knowledge and experience to his work.
Utrecht University, Twente University & National University Hospital of Singapore
Gert Storm is a (bio)pharmaceutical scientist specialized in Targeted Drug Delivery/Nanomedicine.
He keeps professor
positions at the Department of Pharmaceutics of the Utrecht University (Utrecht, The Netherlands), at the Department
Advanced Organ Bioengineering and Therapeutics of the University of Twente (Enschede, The Netherlands), and at the
Department of Surgery at the National University of Singapore.
He is the (co-)author of more than 650 publications (H-index
120, Google Scholar, January 2023), and since 2014 every year in the Highly Cited Researcher lists of Clarivate Analytics
(Researcher ID: O-8696-2016).
Dept. of Molecular Chemistry and Materials Science, Weizmann Institute of Science
Prof. Mordechai Sheves studied chemistry and earned PhD degree (1979) from the Weizmann Institute of Science and
completed his postdoctoral work at Columbia University.
He headed the Weizmann Institute’s Chemical Research Support Unit (1994- 2004) and served as Dean of the Faculty of
Chemistry (2004-2006). Prof. Sheves is the incumbent of the Ephraim Katzir-Rao Makineni Professorial Chair in Chemistry.
He served as Vice President for Technology Transfer for the Weizmann Institute and as the Chairman of the Board of Directors
of Yeda Research and Development Company Ltd.
Prof. Sheves is the recipient of numerous awards, including the Landau Research Prize (1977), the Ernst David Bergmann Prize
for Chemistry (1985), and the Israel Science Foundation’s prestigious Center of Excellence Grant (1999). In 1992, he served
as a Visiting Professor at the University of Illinois (Champaign/Urbana), where he worked in the Beckman Institute and in the
Department of Biophysics.
Director & Chief Medical Officer
International Public Sector Health, Amazon Web Services
Dr Rowland Illing is the Chief Medical Officer and Director of International Public Sector Health for Amazon Web Services (AWS). He has responsibility for healthcare strategy and operations for AWS internationally. This encompasses healthcare providers, payors and health technology companies. He is particularly interested in Health Equity and Sustainability in Healthcare.
Rowland is an Honorary Associate Professor at University College London, who trained in both Cambridge and Oxford Universities. He is an Academic Interventional Radiologist, Member of the Royal College of Surgeons of England, Fellow of the Royal College of Radiologists and Senior Fellow of the Faculty of Medical Leadership and Management in the UK. He continues to present and publish on topics including digital healthcare and AI, is a member of the Digital Health Roster of Experts for the WHO and member of the European AI Alliance for the European Commission.
Carle Illinois College of Medicine, University of Illinois Urbana-Champaign
Mark Cohen, MD, FSSO, FACS, is Dean of the Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign
and Senior Vice President and Chief Academic Officer of Carle Health. He is also a Professor of Surgery and Biomedical and Translational Sciences in the Carle Illinois College of Medicine and Professor of Bioengineering in the Grainger College of Engineering at the University of Illinois, Urbana-Champaign. Dean Cohen holds a B.S. degree in chemical engineering and M.D. from Washington University in St. Louis. He is board certified by the American Board of Surgery and is a Fellow of the American College of Surgeons and is a Fellow of the Society of Surgical Oncology.
Alpha Tau Medical
Mr. Sofer specializes in medical device development, regulation, reimbursement and marketing, and has more than 20 years
of experience in business across different industries including homeland security, manufacturing and trading. He has held
executive positions in a number of public and private enterprises, and has broad experience with the capital markets as well as mergers and acquisitions. From 2003 - 2015 he was co-founder, CEO and Board member at Brainsway, an Israeli medical device company, and previously served as CFO at Hofit Company. Mr. Sofer holds a B.Sc. in Accounting and Finance from the Jerusalem College of Technology.
Davidi is the CEO of UltraSight, a digital health pioneer working to increase access to cardiac care through the power of
machine learning. UltraSight real-time guidance system aims to bring the benefits of cardiac imaging to more healthcare
professionals in multiple care settings and allow patients easier access to cardiac treatment. In 2013 Davidi founded Lumos, a
disruptive solar company. As CEO, Davidi led the company’s growth, impacting the lives of more than 1 million people. He has
previously held executive positions at Comverse Technologies and NICE Systems, focusing on new business creation. Davidi is a fellow at Unreasonable Impact.
MRS-Singapore Chair Professor
School of Materials Science and Engineering, Nanyang Technological University
Professor Nam-Joon Cho is a leading scholar in material science and infectious disease medicine.
He pioneered sustainable healthcare solutions, including antiviral peptide technology for COVID-19 drugs and eco-friendly plastics made from plant
pollen. Dr. Cho coined the term ‘cross-economy’, a paradigm for material innovation, and serves as Project Lead at Stanford University's Antiviral Drug Discovery Centre.
He has published 280+ scientific papers in top journals, licensed technologies
to biotech companies with $26M+ investment funding, and mentored alumni who became faculty and entrepreneurs.
Dr. Cho is President of the Korean Scientist and Engineers Association in Singapore and a member of the National Academy of Engineering of Korea. He holds degrees from Stanford University and UC Berkeley.
Nanomechanics Lab, MIT & Nanyang Technological University
Professor Ming Dao is the Principal Investigator and Director of MIT’s Nanomechanics Laboratory. He is a Fellow of
the American Society of Mechanical Engineers (ASME) and named the 2012 Singapore Research Chair Professor in
Bioengineering and Infectious Disease by MIT. He had been a visiting/adjunct professor with the National Institute of Blood Transfusion, France (2016-2017), Xi’an Jiaotong University, China (2011-2020) and Nanyang Technological University,
Singapore (2018-present). He is ranked as a Top 2% Scientist by Ioannidis/Stanford University and a top 0.5% researcher in
both citation and h-index by Exaly.com. He has also chaired or co-chaired18 international symposiums/workshops/webinar series.
Alpha Tau Medical
Ronen Segal has more than 20 years of top leadership and executive roles in various fields. He has a multi-disciplinary
technological and managerial background. He served in a variety of senior managerial and development positions, including CTO, Deputy CEO & Head of BD of Brainsway, a publicly traded neuroscience company, bringing its technology from the bench to the market with 3 FDA approvals and more than 100,000 patients treated. He also founded and severed as the Chairman of
the BSMT - the Israeli Brain consortium. Previously, he co-founded WiTech communications, which was acquired by Kodak. Before that, Mr. Segal headed several large-scale technological projects at MAFAT (Ministry of Defense R&D division) and the Navy Submarines R&D Unit.
Department of Chemistry, KAIST
Dr. David G. Churchill is a full professor of Chemistry at KAIST (Daejeon, Korea) and leads his research group, named the
molecular logic gate laboratory, mainly on a variety of synthetic chemistry projects. Interested in neurodegenerative disease,
aging, inflammation, and trace element research, he has formed collaborations in many countries. Having received awards
in teaching, international cooperation, and research, he is currently the president of the Korean Association of Selenium Research and Editor in Chief of Main Group Chemistry (IOS). This year, he is the head organizer of “Se2023,” the 9th international Selenium conference focused on selenium chemistry, biology, and medicine, which is being
held at KAIST (June 26-29, 2023).
Associate Director & Distinguished Professor
Institute for Basic Science & UNIST
Orlando D. Scharer studied the ETH Zurich, Switzerland (MSc) and Harvard University, y, USA (PhD) and did postdoctoral studies at Erasmus University, Netherlands. He held faculty positions at the University of Zurich, Switzerland (1999-2005) and Stony Brook University, NY, USA (2005-2016) before taking up his current positions in Ulsan, Korea, as Associate Director at the
Center for Genomic Integrity of the Institute for Basic Science and Distinguished Professor of Life Sciences at UNIST. His research combines chemical and biological approaches to study the roles of pathways that maintain the stability of the human genome in cancer formation and therapy.
Director / Distinguished Professor
Institute for Basic Science / UNIST
Rodney S. Ruoff. Distinguished UNIST Professor and director of the IBS Center for Multidimensional Carbon Materials. BS
in Chemistry (UT Austin), and Ph.D. in Chemical Physics (UIUC). Cockrell Family Regents Chair Professor (UT Austin; 2007-2013) and John Evans Chair Professor (Northwestern University; 2000-2007). RSR has made pioneering discoveries in
carbon science for > 25 years, including leading to a deeper understanding of: fullerenes, nanotubes, diamond, graphite oxide, graphene oxide, and graphene, among others. He is a Fellow of the MRS, APS, AAAS, and RSC, and recipient of the 2014
Turnbull Prize (MRS) and the 2018 James C. McGroddy Prize (APS).
Ju Young Seok
Associate Professor / co-founder
Korea Advanced Institute of Science and Technology / Genomics co-founder of Genome Insight Inc.
Professor Joo Young Seok, from KAIST, is a physician-scientist who graduated from Seoul National University College of
Medicine in 2007 and completed his graduate studies at the same institution in 2010. His area of expertise is cancer genomes.
In 2020, he co-founded Genome Insight, a company that focuses on precision cancer medicine using genomic bioinformatics
technology. Professor Joo is a member of the Young Korean Academy of Science and Technology (Y-KAST) and holds the Suh Kyungbae Foundation Young Professor Fellowship. Currently, he is also involved in the Leader Project of the Korea Research Foundation.
Jin Hyeob Ryu
Ryu Branden is the CEO and founder of Bioorchestra. He obtained his doctorate in pathology, immunology, and microbes from the University of Tokyo School of Medicine. Following an internship at Harvard-MIT Health Science and Technology and Massachusetts General Hospital, he conducted research at Harvard Medical School.
In 2016, he established Biorchestra with the goal of developing RNA-based therapeutics, where he currently serves as CEO. Branden is credited as the inventor of candidate molecules for RNA treatments and RNA drug delivery systems, which form the foundation of Biorchestra's technologies. He discovered novel RNA biomarkers for degenerative brain disease and developed an RNA therapeutic agent for its treatment.
Under CEO Ryu Branden's leadership, Biorchestra has expanded its focus to include neurological diseases, cancer, chronic conditions, and rare diseases using RNA-based treatment approaches. Since 2017, the company has filed over 160 patent applications.
You Seok Hwan
Chairman & CEO
Chairman You Seok Hwan is the founder of Rokit Healthcare, a leading company in the global market for patient-tailored organ regeneration and anti-aging. The company utilizes convergence technology combining artificial intelligence and 4D
bioprinting, spearheading a new paradigm in the bio-healthcare industry. With over 30 years of experience, Chairman You has successfully managed global corporations, such as Celltrion Healthcare, Tyco International, and Daewoo Motors and played a key role in pioneering new markets. He now leads Rokit Healthcare, driving the company's growth and innovation.
Woo Joe, General Manager of Lotte Healthcare, completed his major in computer science at Boston College. Starting from
2002, he has held positions in overseas marketing and mobile handset product planning at LG Electronics. Over the years,
he has established himself as a digital healthcare expert. In 2010, he served as a product manager for SK Telecom's new
healthcare business development and health management service platform. Later, in 2014, he became the general product
manager for Samsung's health service platform at Samsung Electronics.
In 2021, Woo Joe joined Lotte Group with the objective of developing a personalized healthcare platform, which is considered
a new growth engine for the company. Since April 2022, he has been responsible for leading Lotte Healthcare's business
Lee Sang Yup
Senior Vice President for Research & Distinguished Professor
Distinguished Professor Lee Sang Yup, from the Department of Chemical and Biomolecular Engineering at KAIST, currently holds the position of Vice President for Research at KAIST. He is a member of the National Science and Technology Advisory Council and serves as the president of the Korean Society of Biological Engineering. Additionally, he is the vice president of the National Academy of Engineering of Korea.
Professor Lee is renowned for creating the field of systems metabolism engineering and has developed various environmentally friendly chemical production technologies using microbial cell factories. Notably, he holds the distinction of being a foreign member of the National Academy of Sciences of the United States, the National Academy of Engineering of the United States, and the Royal Society of England, concurrently. Among many awards
he received include Korea's Best Science and Technology Award, Ho-Am Prize, POSCO’s Cheong-Am Award, ENI Award, the Samson Prize, and more.
Park Han soo
CEO / Professor
Genome & Co. / GIST
CEO Park Han-soo is CEO in the research and development division at Genome & Co. Since 2016, he has been a professor in the Department of Biotechnology at the Gwangju Institute of Science and Technology (GIST). CEO Park Han-soo earned
his master's and doctoral degrees from Seoul National University School of Medicine and subsequently worked as a senior researcher at Harvard Medical School. He also served as a Principal Investigator at The Jackson Laboratory.
Upon returning to Korea, he founded Genome & Co., a global drug development company, where he leads research and development efforts in areas such as microbiome treatments and novel targeted immune anti-cancer drugs. CEO Park's professional expertise encompasses research on the anticancer functions of microbiome (2021) and the investigation of mechanisms behind new targeted immune anti-cancer drugs (2023).
Lee Ki Won
Chair / Co-president
FoodTech in Seoul National University / Korea FoodTech Council
Lee Ki-won, head of the Department of Food Technology at Seoul National University, is a professor of Food Biotechnology at Seoul National UniversityHe is the chief professor of the Food Technology Chief Executive course. Currently, he is a full member of the Korea Institute of Science and Technology,He is the co-chairman of the Korea Food Tech Council. Professor Lee Ki-won said, "A customized dietary design platform using AI, customized phytostical,As an authority in the field of commercialization of precision food medicine technology such as customized biofarm, he received the Seoul National University Industry-Academic Cooperation Award and the Ministry of Agriculture, Food and Rural Affairs Science and Technology Awardhave been
suspicious of. He is also the founder of Bobsonu, a subsidiary of Seoul National University Holdings, and is currently serving
as a CTO. Recently, he's a member of the presidentAs a member of the Special Committee on Agriculture, Fisheries and Rural Affairs, he is providing policy direction advice for sustainable development.
Yoon Seok Jin
Korea Institute of Science and Technology (KIST)
Yoon Seok Jin, president of the Korea Institute of Science and Technology (KIST), has been leading KIST's innovation by strengthening challenging research, innovating the evaluation system, and supporting industrial innovation. He has served as the head of the National Science and Technology Research Council (NST) Convergence Research Division and vice president of KIST, and currently serves as the chairman of the National Technology Level Evaluation Committee and a civilian member of
the National Advanced Strategic Industry Committee. In recognition of this achievement, he was awarded the Order of Science and Technology Innovation in 2022.
Wang Kyu Chang
National Academy of Medicine of Korea
Wang Kyu-Chang, President of the National Academy of Medicine of Korea, is a Professor Emeritus of the College of Medicine at Seoul National University, specializing in pediatric neurosurgery. In addition to his academic roles, he also works as a visiting doctor at the National Cancer Center.
Throughout his career, Wang Kyu-Chang has held prestigious positions including Dean of Seoul National University College of Medicine, President of the Korean Society for Brain and Neural Sciences, and President of the International Society of Pediatric Neurosurgery. Beyond his expertise in pediatric neurosurgery, he has shown a keen interest in medical education. As President of the National Academy of Medicine, he has made significant efforts to enhance the development of medical science in Korea, hoping to address issues regarding its fragmentation and lack of systematization.
Lee Yong Hoon
President Lee Yong Hoon is currently serving as the 4th President of UNIST (Ulsan National Institute of Science and Technology). He has held prestigious roles including Vice President of The Korean Federation of Science and Technology Societies, Vice President of the National Academy of Engineering of Korea, and Member of the Science and Technology Basic
Plan Establishment Committee. He is also a civilian member of the Hydrogen Economy Committee.
Before assuming his current position at UNIST, President Lee served as a professor at the Department of Electrical and Electronic Engineering at the Korea Advanced Institute of Science and Technology (KAIST). Throughout his career, he has held various leadership positions including Dean of the University, Dean of the College of Information Science and Technology, Vice-Chancellor of ICC, and Vice-Chancellor of Academic Affairs. President Lee is an expert in communication signal processing and AI. He has made significant contributions to his field, with 219 papers published in international journals and conferences. He obtained his bachelor's and master's degrees in electrical engineering from Seoul National University and a doctorate in electrical engineering from the University of Pennsylvania.
President of Ulsan Institute of Science and Technology since November 2019
Vice President of Academic Affairs, Korea Advanced Institute of Science and Technology (KAIST),from July 2011 to March 2013
Dean of the College of Engineering and the College of Information Science and Technology at KAIST from November 2005 to June 2011
Lee Seung kyou
Korea Biotechnology Industry Org.
Vice Chairman Lee Seung Kyou serves as the Vice President of the Korea Bio Association, representing Korea's bio industry. He
actively contributes as an expert in the bio industry for the government and local governments.
Lee Seung Kyou holds several important positions. He is currently a member of the Bio Special Committee of the National Science and Technology Advisory Council, as well as a director and investment review member of the National New Drug Development Foundation (KDDF). In addition, he serves as a member of the pan-departmental infectious disease response R&D promotion committee under the National Science and Technology Advisory Committee. He also contributes as an
advisory member of the Special Committee on Human Resources for the Ministry of Science and ICT's future initiatives, a member of the Special Committee on Industrial Technology Protection and Biotechnology, and a member of the KOSDAQ Market Corporate Review Committee.